Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(60.0%)
N/A
2(40.0%)
5Total
Phase 3(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06534697Not ApplicableNot Yet Recruiting

Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty

Role: lead

NCT02698995Phase 3Completed

Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia

Role: lead

NCT02749162Phase 3Completed

Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction

Role: lead

NCT02750917Phase 3Completed

Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty

Role: lead

NCT02534610Not ApplicableCompleted

Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty

Role: lead

All 5 trials loaded